Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Gynaecomastia
ADR ID BADD_A01895
ADR Hierarchy
05      Endocrine disorders
05.05      Endocrine disorders of gonadal function
05.05.02      Male gonadal function disorders
05.05.02.003      Gynaecomastia
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.04      Breast disorders NEC
21.05.04.003      Gynaecomastia
Description Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males. [MeSH]
MedDRA Code 10018800
MeSH ID D006177
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Breast enlargement male | Breast enlargement male bilateral | Enlargement breast male | Gynaecomastia | Gynecomastia | Gynaecomastia aggravated | Gynecomastia aggravated | Breast enlargement male unilateral | Male Breast Enlargement | Breast Enlargement, Male | Enlargement, Male Breast | Infant Gynecomastia | Gynecomastia, Infant | Newborn Gynecomastia | Gynecomastia, Newborn | Adolescent Gynecomastia | Gynecomastia, Adolescent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02348Verapamil--
BADD_D02349Verapamil hydrochloride--
BADD_D02383Zidovudine--
BADD_D02389Ziprasidone hydrochloride--
BADD_D02391Ziprasidone mesylate--
BADD_D02396Zonisamide--
BADD_D02398Zuclopenthixol--
BADD_D02490Apalutamide0.002436%
BADD_D02587Relugolix0.002269%
The 9th Page    First    Pre   9    Total 9 Pages